Liquidation10826367Private limited companyCambridge

CRITICAL PRESSURE LIMITED

Significant control: Professor James Mitchell Leiper (25–50%)

In liquidationThe company is being wound up. A liquidator deals with its affairs, assets and creditors' claims. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Critical Pressure Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Critical Pressure Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

CRITICAL PRESSURE LIMITED is a liquidation private limited company (company number 10826367) incorporated on 20 June 2017, registered in Cambridge. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (total exemption full) but not yet parsed into this record.

There are 196 companies in research and experimental development on biotechnology in Cambridge with filed accounts; the median reports net assets of £15k and is 7 years old.

Ownership and control

1 active · 3 other

PJ
Professor James Mitchell Leiper
Individual · since 24 November 2021
- owns 25–50% of shares
25–50%
PJ
Professor James Mitchell Leiper
Individual · since 20 June 2017 · ceased 13 October 2017
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
SP
Mr Simon Paul Fabian Lambden
Individual · since 20 June 2017 · ceased 13 October 2017
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
persons with significant control statement · since 13 October 2017 · ceased 24 November 2021

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 20 June 20179 yrs ago
First accounts due: 20 March 20192779 days overdue
Confirmation statement due: 4 July 2027in 249 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Total Exemption Full

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 20 June 2017
Register status is not ActiveLiquidation

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

04 Jul 2027Confirmation statement duein 249 days
20 Mar 2019First accounts due2779 days overdue
20 Jun 2017Incorporated

Similar companies in Cambridge

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 20 June 2017 · in Jun 2017.

Reminders for CRITICAL PRESSURE LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.